Pencil Biosciences is developing a fully synthetic, modular gene editing technology that operates independently of CRISPR, enabling precise modulation of genetic sequences. This technology aims to provide new therapeutic options for patients with rare diseases by addressing the limitations of existing gene editing methods.
Funding
$10.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current gene editing technologies, like CRISPR, have limitations in terms of precision, delivery, and off-target effects, hindering their effectiveness in treating rare diseases. These limitations can lead to unintended mutations and safety concerns, restricting the therapeutic potential of gene editing.
Solution
Pencil Biosciences is developing a fully synthetic, modular gene editing technology that operates independently of CRISPR. This next-generation approach aims to overcome the limitations of existing methods by offering enhanced precision and control over genetic modifications. The technology's modular design allows for customization and optimization for specific therapeutic applications, potentially expanding the range of treatable rare diseases. By avoiding the use of CRISPR components, Pencil Biosciences seeks to minimize off-target effects and improve the safety profile of gene editing therapies.
Target Audience
The primary target audience includes researchers and pharmaceutical companies focused on developing gene therapies for rare diseases, as well as patients with genetic disorders who may benefit from more precise and safer gene editing technologies.
Features
- Fully synthetic composition, eliminating reliance on CRISPR-associated proteins
- Modular design for customizable targeting and editing functions
- Enhanced precision to minimize off-target effects and unintended mutations
- Potential for improved delivery and accessibility to target tissues
- Compatibility with a range of genetic sequences and therapeutic applications